Patton Fund Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,244
Closed -$228K 135
2026
Q1
$228K Hold
1,244
0.04% 394
2025
Q4
$219K Sell
1,244
-602
-33% -$98.4K 0.03% 381
2025
Q3
$259K Buy
+1,846
New +$250K 0.05% 232
2021
Q1
Sell
-4,063
Closed -$995K 98
2020
Q4
$995K Buy
+4,063
New +$1.05M 0.5% 71
2020
Q3
Sell
-5,460
Closed -$1.46M 79
2020
Q2
$1.46M Buy
+5,460
New +$1.64M 0.85% 43

Other funds holding BIIB

Patton Fund Management's BIIB Position: Q2 2026 in Review

Patton Fund Management sold out of Biogen (BIIB) in Q2 2026, closing a stake of 1,244 shares — an estimated $228K sold.

Patton Fund Management first reported a position in BIIB in Q2 2020 and held it in 5 quarters. The position peaked at $1.46M in Q2 2020. 162 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Patton Fund Management reported no remaining Biogen position as of Q2 2026 after selling out during the quarter.
  • Patton Fund Management sold 1,244 Biogen shares in Q2 2026, an estimated $228K.
  • Patton Fund Management first reported a position in Biogen in Q2 2020 and held it in 5 quarters.
  • Patton Fund Management's Biogen position peaked at $1.46M in Q2 2020.
  • 162 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Patton Fund Management's 13F filing for Q2 2026, filed 13 Jul 2026.